Rohto Cooling Eye Drops Recall Spurs Sterility Class Action Lawsuit

Consumers have sued over recalled Rohto Cooling Eye Drops allegedly sold as sterile despite claimed sterility failures. The case could shape refund rights, class claims, and broader scrutiny of eye-drop labeling after a nationwide Class II recall.

Rohto Cooling Eye Drops Recall Spurs Sterility Class Action Lawsuit
Type
Child
Status
Approved
Title (YouTube)
Images Failed (Social)
Do not index
Publish Date (TikTok)
Videos Post IDs (Social)
Hashtags (Social)
Caption
Caption X
Cover
rohto-cooling-eye-drops-recall-sterility-class-action-lawsuit.png
OG Image
rohto-cooling-eye-drops-recall-sterility-class-action-lawsuit.png
Alt Image Text
Flat vector illustration of a Rohto cooling eye drops recall and sterility class action lawsuit, showing an eye drop bottle, eye icon, and legal scrutiny symbols.
Images
Videos
video_1.mp4
Publish Date (Social)
Scheduled (Social)
Scheduled (Social)
Images Posted (Social)
Videos Posted (Social)
Videos Posted (Social)
Featured
Created time
Sep 24, 2026 06:46 AM
Sub-item
Authors
CTA Practice Area (Social)
TikTok Failed (Social)
Videos Post Links (Social)
TikTok Post Links (Social)
Images Post IDs (Social)
YT Post ID
Video Pending Manual (Social)
TikTok Posted (Social)
TikTok Post IDs (Social)
Video Cover (Social)
Images Post Links (Social)
First Comment (Social)
Videos Failed (Social)
Videos Failed (Social)
YT Embedded
YT Embedded
Images Delete (Social)
Videos Delete (Social)
Carousel Video URL (Social)
A new consumer lawsuit is putting Rohto Cooling Eye Drops under a sharper legal spotlight after a major summer recall. On September 17, 2026, plaintiffs filed a proposed class action in federal court in Buffalo, New York, alleging that six Rohto Cooling Eye Drops varieties were sold as “sterile” even though they allegedly fell short of federal sterility standards. The filing came just weeks after Rohto-Mentholatum initiated a voluntary nationwide recall on July 14, 2026, and after the FDA later treated the action as a Class II recall. According to the recall details, the action covered 11,960,623 cartons, or more than 12 million bottles, distributed nationwide.
 

What The Lawsuit Alleges

The complaint, filed in the U.S. District Court for the Western District of New York, names Rohto-Mentholatum Co. Ltd., Rohto Pharmaceutical Co. Ltd., and The Mentholatum Co. as defendants. Claim Depot reports that the plaintiffs allege Rohto sold six affected product lines with a front label stating “sterile,” while the eye drops allegedly did not satisfy the federal sterility standard. The case centers on six recalled varieties: All-In-One, Max Strength, Optic Glow, Digi Eye, Dry Aid, and Cool Relief, according to the recalled product list.
The lawsuit also goes beyond the recall itself. Plaintiffs allege that every recalled carton was adulterated and misbranded under the Federal Food, Drug, and Cosmetic Act, and they pair those federal allegations with state-law claims for false advertising, consumer fraud, warranty breaches, and unjust enrichment. Claim Depot’s summary says the complaint pleads a proposed nationwide class plus California, Illinois, and multistate subclasses based on state consumer protection statutes.

Why Sterility Matters So Much In Eye Drop Cases

For non-lawyers, the phrase “lack of assurance of sterility” can sound technical and abstract. In general terms, it points to a concern that a manufacturer could not adequately confirm the product met the contamination safeguards expected for a drug placed directly into the eye. That matters because ophthalmic products are especially sensitive: they are used on a vulnerable part of the body, often without a second barrier between the liquid and the user’s eye.
The recall classification helps frame the risk, though it does not resolve the merits of the lawsuit. FDA explains that recalls are categorized as Class I, II, or III based on the relative degree of health hazard. Here, the Rohto recall was treated as Class II, which generally refers to products that may cause temporary or medically reversible adverse health consequences, with serious harm considered less likely. EyeDropSafety.org likewise lists the reason for recall as lack of sterility assurance.
That distinction is important. A Class II recall is still a serious event, especially when it involves a product marketed as sterile and sold for eye use. But it does not automatically establish that every purchaser suffered a physical injury. In many product-labeling cases, the legal fight turns on alleged economic harm: consumers say they paid for one thing and received something materially different.

The Recall’s Scope Is Unusually Large

The scale of this recall is one reason the lawsuit may draw attention well beyond routine false-advertising litigation. According to the recall quantity listed by EyeDropSafety.org, the action involved 11,960,623 cartons manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. The affected lots carried expiration dates extending into 2029, which may have increased the number of products still sitting in homes, medicine cabinets, warehouses, and retailer inventories when the recall surfaced.
The recalled lineup also spanned multiple familiar Rohto Cooling Eye Drops varieties rather than a single niche SKU. That broader footprint could become relevant if the plaintiffs try to show common marketing themes, uniform packaging statements, or a widespread consumer understanding tied to the word “sterile.”

How Consumer Class Actions Often Work After A Recall

A recall and a class action are related, but they are not the same thing. A recall is typically a product-removal or correction process. A consumer class action, by contrast, is a civil case asking whether buyers are entitled to money or other relief because of how a product was marketed or sold.
Here, Claim Depot says the plaintiffs are seeking actual, statutory, and punitive damages plus fees and costs. The site also says the complaint asks the court to order full refunds for proposed class members, including some consumers who may no longer have the bottle or carton. If the case advances, one of the early disputes may involve whether buyers across different states can be grouped together, or whether differences in state consumer laws make a nationwide class harder to certify.
Another likely issue is proof of injury. In a contamination or sterility case, some people may claim physical symptoms, while others may focus on the purchase itself and argue they would not have bought the product, or would have paid less, had they known about the alleged sterility problem. Courts often treat those theories differently depending on the facts, the state-law claims asserted, and how the complaint frames the alleged loss.

What The Filing May Mean For Consumers

At this stage, the case appears to be in its early pleadings phase. Claim Depot reports there is no settlement, no claims process, and no money available at this time. That means consumers following the case may see months of motion practice before any resolution takes shape.
For people who purchased or used the recalled products, the practical implications may vary. Some may be monitoring for refund options through ordinary retail channels. Others may be watching the litigation for class notices or court-approved compensation programs if the case survives dismissal and later reaches settlement talks. Consumers who experienced irritation or other medical issues may also view the lawsuit differently from purchasers raising purely labeling-based loss claims.

What Companies And Retailers May Be Watching

Manufacturers, retailers, and compliance teams may also be paying attention to this case because it fits into a broader pattern of litigation involving over-the-counter eye products and contamination-related allegations. When a label uses a term as specific as “sterile,” plaintiffs often argue that the word conveys an objective product characteristic, not mere marketing puffery. That can make these disputes less about advertising style and more about measurable regulatory compliance.
The suit may also test how far plaintiffs can go in using federal standards inside state-law consumer claims. Even where a private party cannot directly enforce the FDCA as a standalone claim, complaints often reference federal regulations and recall findings as evidence supporting allegedly misleading statements under state law. An attorney following the Rohto case might look closely at how the court handles that overlap.

What Affected Buyers May Want To Consider

People who bought Rohto Cooling Eye Drops from the recalled lots may want to consider keeping purchase records, product photos, lot numbers, packaging, retailer receipts, and any communications tied to the recall. For consumers who experienced symptoms after using the products, some attorneys also look at medical records, pharmacy histories, and timing evidence connecting product use to reported eye issues.
In situations like this, an attorney might help evaluate whether a person’s circumstances line up more closely with a consumer-refund claim, a personal-injury claim, or neither. That kind of case assessment often turns on product identification, documented use, and whether the person has evidence of financial loss, physical symptoms, or both.
If you're facing legal challenges, ReferU.AI analyzes billions of court records to match you with attorneys who've successfully represented cases just like yours.